首页|亚低温对新生儿缺氧缺血性脑病患儿血清泛素羧基末端水解酶-L1、低氧诱导因子-1α表达水平及神经发育结局的影响

亚低温对新生儿缺氧缺血性脑病患儿血清泛素羧基末端水解酶-L1、低氧诱导因子-1α表达水平及神经发育结局的影响

扫码查看
目的 探讨亚低温对新生儿缺氧缺血性脑病(hypoxic-ischemic encephalopathy,HIE)患儿血清泛素羧基末端水解酶-L1(ubiquitin carboxy-terminal hydrolase-L1,UCH-L1)、低氧诱导因子-1a(hypoxia-inducible factor-1α,HIF-1α)表达水平及预后的影响.方法 选取 2015年8月至2022年8月邯郸市妇幼保健院新生儿重症监护病房(neonatal intensive care unit,NICU)收治的 110 例中重度HIE患儿作为研究对象.根据家属是否同意患儿接受亚低温治疗,将患儿分为亚低温治疗组(n=70)和传统治疗组(n=40);亚低温治疗组患儿除常规治疗外,于出生后 0~6 h 实施选择性头部亚低温治疗.传统治疗组患儿给予常规治疗;治疗前和治疗后第 3 天,采用酶联免疫吸附实验双抗夹心法检测UCH-L1、HIF-1α表达水平.随访患儿出生后 12~15 个月神经发育结局.统计学方法采用独立样本t检验、配对t检验、χ2 检验或Fisher确切概率法.结果 亚低温治疗组与传统治疗组治疗后血清UCH-L1[(1.9±0.4)与(3.1±0.3)µg/L,t=16.495,P<0.001)]、HIF-1α表达水平[(1.40±0.22)与(2.75±0.19)µg/L,t=32.486,P<0.001)]比较,亚低温治疗组明显低于传统治疗组;亚低温治疗组患儿治疗后血清UCH-L1 表达水平低于治疗前[(1.9±0.4)与(3.3±0.5)µg/L,t'=18.293,P<0.01)].亚低温治疗组和传统治疗组在治疗 3 d后,虽然两组血清中HIF-1α表达水平均出现高于治疗前[(1.40±0.22)与(1.23±0.29)µg/L,t'=3.907,P<0.001;(2.75±0.19)与(1.27±0.35)µg/L,t'=23.504,P<0.001],但是,亚低温抑制血清HIF-1α表达水平升高的效果明显优于传统治疗组.随访结果显示,亚低温治疗组患儿神经发育正常的比例高于传统治疗组[68.6%(48/70)与32.5%(13/40),χ2=13.408,P<0.001];亚低温治疗组神经发育迟缓的比例低于传统治疗组[11.4%(8/70)与37.5%(15/40),χ2=10.462,P<0.001)].结论 亚低温治疗可以明显降低中重度HIE患儿血清UCHL1 表达水平,抑制血清HIF-1a表达水平升高的作用明显优于传统治疗,这可能是低温治疗的神经保护机制之一.
Effect of hypothermia on the expression level of serum ubiquitin carboxy-terminal hydrolase-L1 and hypoxia-induced factor-1α and neurodevelopmental outcomes in neonatal hypoxic-ischemic encephalopathy
Objective To explore the effect of hypothermia treatment on the expression levels of serum ubiquitin carboxy-terminal hydrolase-L1(UCH-L1)and hypoxia-induced factor-1α(HIF-1α)and neurodevelopmental outcomes in neonatal hypoxic-ischemic encephalopathy(HIE).Method From August 2015 to August 2022,110 children with moderate to severe HIE admitted in the neonatal intensive care unit(NICU)of Handan Maternal and Child Health Hospital were selected.According to whether family members agreed to receive mild hypothermia treatment,the cases were divided into hypothermia treatment group(n=70)and traditional treatment group(n=40).The hypothermia treatment group was given selective head cooling(SHC)treatment from 0 to 6 hours after birth in addition to conventional treatment.The children in the traditional treatment group were given conventional treatment.The expression levels of UCH-L1 and HIF-1α in all children were detected by enzyme-linked immunosorbent assay double anti-sandwich assay before treatment and on the 3rd day after treatment.Neurodevelopmental outcomes were followed up 12 to 15 months after birth.The Independent sample t-test,paired sample t-test,χ2 test or Fisher exact probability method were used for statistical analysis.Result The expression levels of serum UCH-L1[(1.9±0.4)vs(3.1±0.3)µg/L,t=16.495,P<0.001]and HIF-1α[(1.40±0.22)vs(2.75±0.19)µg/L,t=32.486,P<0.001)]in mild hypothermia treatment group were significantly lower than those in traditional treatment group after treatment.The expression level of serum UCH-L1 in mild hypothermia group after treatment was lower than before treatment[(1.9±0.4)vs(3.3±0.5)µg/L,t=18.293,P<0.01].The expression level of serum HIF-1α in both groups were higher than those before treatment[(1.40±0.22)vs(1.23±0.29)µg/L,t'=3.907,P<0.001]and[(2.75±0.19)vs(1.27±0.35)µg/L,t'=23.504,P<0.001],but the results of mild hypothermia treatment inhibition of serum HIF-1α increase were significantly better than those of traditional treatment.Follow-up results showed that the proportion of normal neurodevelopment in mild hypothermia treatment group was higher than that in traditional treatment group[68.6%(48/70)vs 32.5%(13/40),χ2=13.408,P<0.001].The proportion of neurodevelopmental retardation in mild hypothermia treatment group was lower than that in traditional treatment group[11.4%(8/70)vs 37.5%(15/40),χ2=10.462,P<0.001].Conclusion The serum UCH-L1 level of children with moderate to severe HIE could be significantly decreased in mild hypothermia treatment group.Moreover,the effect of mild hypothermia treatment on the elevation of serum HIF-1α level is significantly better than that of the traditional treatment group,which may be one of the neuroprotective mechanisms of hypothermia level.

HypothermiaNeonatal hypoxic-ischemic encephalopathyUbiquitin carboxyl-terminal hydrolase-L1Hypoxia-inducible factor-1αIntervention mechanism

吕红艳、尹晓娟、刘芳、李亚梅、王秋丽、任朋顺、陈长春、张晓媛、封志纯

展开 >

邯郸市妇幼保健院 新生儿科,河北 邯郸 056002

解放军总医院儿科医学部 解放军总医院第七医学中心儿科研究所 出生缺陷防控关键技术国家工程实验室 儿童器官功能衰竭北京市重点实验室,北京 100700

解放军联勤保障部队第九八〇医院 儿科,河北 石家庄 050082

河北省邢台市第九医院 儿科,河北 邢台 055250

展开 >

亚低温 新生儿缺氧缺血性脑病 泛素羧基末端水解酶-L1 低氧诱导因子-1α 干预机制

河北省科技计划项目

162777201

2024

发育医学电子杂志
人民卫生出版社

发育医学电子杂志

CSTPCD
影响因子:0.212
ISSN:2095-5340
年,卷(期):2024.12(1)
  • 7